The Contractor shall be responsible for regulatory submissions to support the chemoprevention agent development and clinical research program. The Contactor shall develop and implement procedures for accessing, reviewing, and compiling safety, and clinical data for possible inclusion in Investigational New Drugs (IND) and other regulatory submissions.